Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion type Assertion NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_head.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion description "[We evaluated the presence of the progesterone receptor (PR), estradiol receptors (ERs), and aromatase in 5 patients with primary pigmented nodular adrenal disease (PPNAD), 15 adrenocortical adenomas (ACAs) and adjacent normal tissues, 12 adrenocortical carcinomas (ACCs), and 3 normal adrenal glands (NA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_provenance.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion evidence source_evidence_literature NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_provenance.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion SIO_000772 18508999 NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_provenance.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion wasDerivedFrom befree-20140225 NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_provenance.
- NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_assertion wasGeneratedBy ECO_0000203 NP581029.RAs5Mp71-lKSHqmZ6pf1hCJoHawgSxj2Jgnbrqm7xzwLA130_provenance.